Nicotinamide Adenine Dinucleotide (nad+ recalls

The FDA has published 2 recalls involving Nicotinamide Adenine Dinucleotide (nad+ since 2025. The latest was reported on 2 Jul 2025. Most were for sterility. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls2since 2025
Last 12 months0reported
Class I00% of total
Ongoing2latest 2 Jul 2025

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 0 0%Class II 2 100%Class III 0 0%

Why nicotinamide adenine dinucleotide (nad+ is recalled

By year

Ongoing nicotinamide adenine dinucleotide (nad+ recalls

2 active

All nicotinamide adenine dinucleotide (nad+ recalls, newest first

2 total

Should you stop taking Nicotinamide Adenine Dinucleotide (nad+?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.